• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Arcturus Therapeutics Holdings Inc (NQ:ARCT)

    20.52 -1.21 (-5.59%)
    Streaming Delayed Price Updated: 11:40 AM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Arcturus Therapeutics Holdings Inc

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Arcturus Therapeutics to Present at Upcoming Investor and Scientific Conferences
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Expert Ratings For Arcturus Therapeutics
    Within the last quarter, Arcturus Therapeutics (NASDAQ:ARCT) has observed ... 
    Via Benzinga
    Analyst Ratings For Arcturus Therapeutics
    Analysts have provided the following ratings for Arcturus Therapeutics (NASDAQ: 
    Via Benzinga
    Mid-Day Market Update: ExOne Rises Following Acquisition News; LifeStance Health Shares Plummet
    Midway through trading Thursday, the Dow traded down 0.32% to 35,369.96 while the NASDAQ rose 0.01% to 14,766.11. The S&P also fell, dropping 0.10% to 4,443.23. The U.S. has... 
    Via Benzinga
    Topics Stocks
    Understanding Arcturus Therapeutics's Unusual Options Activity
    On Tuesday, shares of Arcturus Therapeutics (NASDAQ:ARCT)... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
    Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd 
    Via Benzinga
    Arcturus Stock, A Covid Play, Flashes Vital Signs
    A Relative Strength Rating upgrade for Alcobra shows improving technical performance. 
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2021
    Upgrades According to Barclays, the prior rating for Albertsons Companies Inc (NYSE: 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers CohBar (NASDAQ:CWBR) stock moved upwards by 68.21% to $2.17 during Wednesday's pre-market session. The company's market cap stands at $134.0 million. The... 
    Via Benzinga
    Arcturus Therapeutics Stock Jumps On mRNA COVID-19 Vaccine Update
    Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) reported a Q2 EPS loss of $(2.07), beating the consensus of $(2.14). The cash balance totaled $433.6 million. After... 
    Via Benzinga
    85 Biggest Movers From Yesterday
    Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
    Via Benzinga
    54 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5... 
    Via Benzinga
    The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    28 Stocks Moving in Tuesday's Pre-Market Session
    Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also... 
    Via Benzinga
    Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
    Toward the end of trading Tuesday, the Dow traded up 0.64% to 35,059.40 while the NASDAQ rose 0.34% to 14,731.57. The S&P also rose, gaining 0.65% to 4,415.65. The U.S. has... 
    Via Benzinga
    Topics Stocks
    99 Biggest Movers From Yesterday
    Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
    Via Benzinga
    88 Biggest Movers From Yesterday
    Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in... 
    Via Benzinga
    75 Biggest Movers From Yesterday
    Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 68.1% to close at $58.25 on Tuesday after the company announced that the it has received approval for a... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Arcturus Therapeutics (NASDAQ:ARCT) stock moved upwards by 29.05% to $44.73 during Tuesday's regular session. As of 12:35 EST, Arcturus Therapeutics's... 
    Via Benzinga
    Mid-Day Market Update: Crude Oil Down 2%; Arcturus Therapeutics Shares Spike Higher
    Midway through trading Tuesday, the Dow traded up 0.11% to 34,878.06 while the NASDAQ fell 0.37% to 14,626.97. The S&P also fell, dropping 0.01% to 4,386.68. The U.S. has the... 
    Via Benzinga
    Topics Stocks
    48 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 64.4% to $7.15 after a Form 4 filing from the company showed 10% shareholder Retail Ecommerce Ventures... 
    Via Benzinga
    Why Arcturus Therapeutics Stock Is Soaring Today
    The company received a green light to advance two COVID-19 vaccine candidates into clinical testing in a second country. 
    Via The Motley Fool
    The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    21 Stocks Moving in Tuesday's Pre-Market Session
    Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares rose 46% to $6.35 in pre-market trading following Form 4 filing from the company’s 10% owner, Retail Ecommerce... 
    Via Benzinga
    Arcturus Announces Approval of Singapore Clinical Trial Application to Advance ARCT-154 and ARCT-165, Next Generation STARR™ mRNA Vaccines Targeting SARS-CoV-2 Variants of Concern, in a Phase 1/2 Study
    From Arcturus Therapeutics Holdings Inc.
    Via Business Wire
    10 Health Care Stocks Showing Unusual Options Activity In Today's Session
    This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
    Via Benzinga
    Arcturus' COVID-19 mRNA Vaccine Candidate To Target Variants, Trial To Start In Vietnam
    The Vietnam Ministry of Health has signed off Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) Clinical Trial Application (CTA) to advance ARCT-154 COVID19... 
    Via Benzinga
    Arcturus Therapeutics Stock Jumps On Establishment Of COVID-19 Vaccine Plant In Vietnam
    Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has collaborated with Vinbiocare to establish a manufacturing facility in Vietnam for its... 
    Via Benzinga
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.